Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.820
-0.070 (-3.70%)
Sep 18, 2026, 4:08 PM HKT

Kintor Pharmaceutical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
31.332.74147.42445.5865.08930.15
Short-Term Investments
---12.5611.88126.58
Cash & Short-Term Investments
31.332.74147.42458.05876.961,057
Cash Growth
-40.79%-77.79%-67.82%-47.77%-17.01%-24.15%
Accounts Receivable
2.862.8----
Other Receivables
1.131.1315.656.48--
Receivables
3.993.9315.656.48--
Inventory
11.0112.092.22-603.5351.36
Restricted Cash
0.52.030.430.435.641.66
Other Current Assets
1.494.466.027.621.77116.15
Total Current Assets
48.2955.25171.73472.561,5081,526
Property, Plant & Equipment
150.54158.02174.23221.84282.48262.3
Long-Term Investments
20.2916.2516.571817.95-
Other Intangible Assets
95.76107.26148.95148.94235.65235.62
Other Long-Term Assets
4.064.033.657.911.244.17
Total Assets
318.94340.81515.13869.232,0552,068

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
31.8532.1240.9681.6180.4172.96
Accrued Expenses
2.653.775.0817.3219.8925.12
Short-Term Debt
132.96514.382040-
Current Portion of Long-Term Debt
-2097.3893.758.97.4
Current Portion of Leases
0.630.611.254.534.442.07
Other Current Liabilities
14.96.087.637.5814.512.2
Total Current Liabilities
182.93127.58166.68224.73318.13219.74
Long-Term Debt
--20133.4177.6147.5
Long-Term Leases
0.060.99-2.295.452.76
Long-Term Unearned Revenue
2.972.973.3219.6619.954.01
Long-Term Deferred Tax Liabilities
23.7726.6831.0431.0438.8238.82
Total Liabilities
209.72158.21221.05411.12559.95412.83

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.350.350.320.320.320.27
Additional Paid-In Capital
-4,3184,2104,1824,1043,359
Retained Earnings
--4,140-3,940-3,785-2,724-1,769
Comprehensive Income & Other
108.874.4723.5860.73114.7765.49
Shareholders' Equity
109.22182.6294.08458.111,4951,655
Total Liabilities & Equity
318.94340.81515.13869.232,0552,068

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
133.5886.6133.01253.92286.39159.73
Net Cash (Debt)
-102.29-53.8614.41204.13590.57897
Net Cash Growth
---92.94%-65.43%-34.16%-23.43%
Net Cash Per Share
-0.21-0.120.030.481.572.52
Filing Date Shares Outstanding
493.81493.81434.2439.4447.5387.59
Total Common Shares Outstanding
493.81493.81434.2439.4447.5387.59
Working Capital
-134.63-72.335.05247.831,1901,306
Book Value Per Share
0.220.370.681.043.344.27
Tangible Book Value
13.4675.34145.13309.171,2601,420
Tangible Book Value Per Share
0.030.150.330.702.813.66
Buildings
-131.7488.8889.2389.2357.66
Machinery
-70.6353.6658.758.2446.78
Construction In Progress
--62109.24105.66125.74